Cutting Edge: The RNA-Binding Protein Ewing Sarcoma Is a Novel Modulator of Lymphotoxin β Receptor Signaling

  • Virgen-Slane R
  • Correa R
  • Ramezani-Rad P
  • et al.
1Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Lymphotoxin β receptor (LTβR) signaling is crucial for lymphoid tissue organogenesis and immune homeostasis. To identify novel regulatory mechanisms for signaling, we implemented a two-step screen that uses coexpression analysis of human fibroblasts undergoing LTβR stimulation and affinity-purification mass spectrometry for the LTβR signaling protein TNFR-associated factor 3 (TRAF3). We identify Ewing sarcoma (EWS) protein as a novel LTβR signaling component that associates with TRAF3 but not with TNFR-associated factor 2 (TRAF2). The EWS:TRAF3 complex forms under unligated conditions that are disrupted following activation of the LTβR. We conclude that EWS limits expression of proinflammatory molecules, GM-CSF, and ERK-2, promoting immune homeostasis.

Cite

CITATION STYLE

APA

Virgen-Slane, R., Correa, R. G., Ramezani-Rad, P., Steen-Fuentes, S., Detanico, T., DiCandido, M. J., … Ware, C. F. (2020). Cutting Edge: The RNA-Binding Protein Ewing Sarcoma Is a Novel Modulator of Lymphotoxin β Receptor Signaling. The Journal of Immunology, 204(5), 1085–1090. https://doi.org/10.4049/jimmunol.1901260

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free